Analysis of BRCA1 germline variants (exons 5, 11 and 20) in breast cancer families from Libya.

IF 16.4 1区 化学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Accounts of Chemical Research Pub Date : 2024-12-31 Epub Date: 2024-05-24 DOI:10.1080/19932820.2024.2356906
Eanas Saleh Elmaihub, Inas Alhudiri, Ahmad M Ramadan, Mouna Eljilani, Adam Elzagheid, Fakria Elfagi, Elham Hassen
{"title":"Analysis of BRCA1 germline variants (exons 5, 11 and 20) in breast cancer families from Libya.","authors":"Eanas Saleh Elmaihub, Inas Alhudiri, Ahmad M Ramadan, Mouna Eljilani, Adam Elzagheid, Fakria Elfagi, Elham Hassen","doi":"10.1080/19932820.2024.2356906","DOIUrl":null,"url":null,"abstract":"<p><p>Breast cancer (BC) is a leading cause of cancer deaths in Libyan women. <i>BRCA1</i> variants differ globally due to the diversity of genetic makeup and populations history. Their distribution, prevalence, and significance in Libyans remain largely unexplored. This study investigated the characteristics and distribution of <i>BRCA1</i> variants in exons 5, 11, and 20 in Libyan families with BC. Thirty-six BC patients at ≤ 45 years, between 46-50 years and with a family history of breast, ovarian, pancreatic or prostate cancer in close relatives, or with triple-negative BC, were selected from 33 unrelated families during 2018-2020 at the National Cancer Institute, Sabratha, Libya. From these 33 families, 20 women (18 BC patients and two unaffected) were screened for <i>BRCA1</i> exons 5, 11 and 20 using Sanger sequencing. All families completed an epidemiology and family history questionnaire. Twenty-seven variants (26 in exon 11 and 1 in exon 20, minor allele frequency of < 0.01) were detected in 10 of 18 unrelated families (55.6%.) Among the 27 variants, 26 (96%) were heterozygous. A frameshift pathogenic variant, c.2643del, and one novel variant c.1366A>G were identified. Furthermore, seven variants with unknown clinical significance were detected: c.1158T>A, c.1346C>G, c.1174C>G, c.3630 G>T, c.3599A>T, and c.3400 G>C in exon 11, and c.5244T>A in exon 20. Six variants with conflicting pathogenicity interpretations, c. 3460T>A, c. 3572 G>A, c. 3700 G>C, c. 1246C>G, c. 1344C>G, and c. 1054 G>A, were also identified. Twelve benign/likely benign variants were identified. Rare <i>BRCA1</i> variants that have not been reported in North Africa were found in Libyan patients. These findings provide preliminary insights into the <i>BRCA1</i> variants that could contribute to hereditary BC risk in Libyans. Further functional, computational, and population analyses are essential to determine their significance and potential impact on BC risk, which could ultimately lead to more personalized management strategies.</p>","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11210411/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/19932820.2024.2356906","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/24 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Breast cancer (BC) is a leading cause of cancer deaths in Libyan women. BRCA1 variants differ globally due to the diversity of genetic makeup and populations history. Their distribution, prevalence, and significance in Libyans remain largely unexplored. This study investigated the characteristics and distribution of BRCA1 variants in exons 5, 11, and 20 in Libyan families with BC. Thirty-six BC patients at ≤ 45 years, between 46-50 years and with a family history of breast, ovarian, pancreatic or prostate cancer in close relatives, or with triple-negative BC, were selected from 33 unrelated families during 2018-2020 at the National Cancer Institute, Sabratha, Libya. From these 33 families, 20 women (18 BC patients and two unaffected) were screened for BRCA1 exons 5, 11 and 20 using Sanger sequencing. All families completed an epidemiology and family history questionnaire. Twenty-seven variants (26 in exon 11 and 1 in exon 20, minor allele frequency of < 0.01) were detected in 10 of 18 unrelated families (55.6%.) Among the 27 variants, 26 (96%) were heterozygous. A frameshift pathogenic variant, c.2643del, and one novel variant c.1366A>G were identified. Furthermore, seven variants with unknown clinical significance were detected: c.1158T>A, c.1346C>G, c.1174C>G, c.3630 G>T, c.3599A>T, and c.3400 G>C in exon 11, and c.5244T>A in exon 20. Six variants with conflicting pathogenicity interpretations, c. 3460T>A, c. 3572 G>A, c. 3700 G>C, c. 1246C>G, c. 1344C>G, and c. 1054 G>A, were also identified. Twelve benign/likely benign variants were identified. Rare BRCA1 variants that have not been reported in North Africa were found in Libyan patients. These findings provide preliminary insights into the BRCA1 variants that could contribute to hereditary BC risk in Libyans. Further functional, computational, and population analyses are essential to determine their significance and potential impact on BC risk, which could ultimately lead to more personalized management strategies.

分析利比亚乳腺癌家族中的 BRCA1 基因变异(外显子 5、11 和 20)。
乳腺癌(BC)是利比亚妇女癌症死亡的主要原因。由于基因构成和人口历史的多样性,BRCA1 变体在全球范围内各不相同。它们在利比亚人中的分布、患病率和意义在很大程度上仍未得到探索。本研究调查了利比亚 BC 患者家庭中 BRCA1 第 5、11 和 20 号外显子变异的特征和分布情况。2018-2020年间,利比亚萨布拉塔国家癌症研究所从33个无血缘关系的家庭中挑选了36名年龄≤45岁、46-50岁之间、近亲中有乳腺癌、卵巢癌、胰腺癌或前列腺癌家族史或患有三阴性BC的BC患者。从这 33 个家庭中,使用 Sanger 测序技术筛查了 20 名女性(18 名 BC 患者和 2 名未受影响者)的 BRCA1 第 5、11 和 20 号外显子。所有家庭都填写了一份流行病学和家族史问卷。结果发现了 27 个变异基因(26 个位于第 11 号外显子,1 个位于第 20 号外显子,小等位基因频率为 G)。此外,还发现了 7 个临床意义不明的变异:第 11 号外显子中的 c.1158T>A、c.1346C>G、c.1174C>G、c.3630 G>T、c.3599A>T 和 c.3400 G>C,以及第 20 号外显子中的 c.5244T>A。此外,还发现了 6 个致病性解释相互矛盾的变体,即 c. 3460T>A、c. 3572 G>A、c. 3700 G>C、c. 1246C>G、c. 1344C>G 和 c. 1054 G>A。还发现了 12 个良性/可能良性变异。在利比亚患者中发现了北非未报道过的罕见 BRCA1 变异。这些发现提供了对可能导致利比亚人遗传性乳腺癌风险的 BRCA1 变异的初步认识。进一步的功能、计算和人群分析对于确定这些变异的意义和对乳腺癌风险的潜在影响至关重要,这最终将有助于制定更加个性化的管理策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Accounts of Chemical Research
Accounts of Chemical Research 化学-化学综合
CiteScore
31.40
自引率
1.10%
发文量
312
审稿时长
2 months
期刊介绍: Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信